Global Dexlansoprazole Sustained Release Capsule market size is predicted to grow from US$ 337 million in 2025 to US$ 465 million in 2031; it is expected to grow at a CAGR of 5.5% from 2025 to 2031.

Global Dexlansoprazole Sustained Release Capsule Market Size, Share and Analysis

The global Dexlansoprazole Sustained Release Capsule market size is predicted to grow from US$ 337 million in 2025 to US$ 465 million in 2031; it is expected to grow at a CAGR of 5.5% from 2025 to 2031. Dexlansoprazole sustained-release capsules were approved by the U.S. FDA in January 2009, under the trade name DEXILANT. For the treatment of heartburn caused by non-erosive gastroesophageal reflux disease (GERD), erosive esophagitis (EE) and maintenance treatment after healing of erosive esophagitis, all of which are administered once a day. United States market for Dexlansoprazole Sustained Release Capsule is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Dexlansoprazole Sustained Release Capsule is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Dexlansoprazole Sustained Release Capsule is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Dexlansoprazole Sustained Release Capsule players cover TAKEDA PHARM, PAR PHARM, TWI PHARM, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the Dexlansoprazole Sustained Release Capsule Industry Forecast looks at past sales and reviews total world Dexlansoprazole Sustained Release Capsule sales in 2024, providing a comprehensive analysis by region and market sector of projected Dexlansoprazole Sustained Release Capsule sales for 2025 through 2031. With Dexlansoprazole Sustained Release Capsule sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dexlansoprazole Sustained Release Capsule industry. This Insight Report provides a comprehensive analysis of the global Dexlansoprazole Sustained Release Capsule landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dexlansoprazole Sustained Release Capsule portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Dexlansoprazole Sustained Release Capsule market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dexlansoprazole Sustained Release Capsule and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dexlansoprazole Sustained Release Capsule. This report presents a comprehensive overview, market shares, and growth opportunities of Dexlansoprazole Sustained Release Capsule market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; 30MG &nbsp;&nbsp;&nbsp; 60MG Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Clinic This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; TAKEDA PHARM &nbsp;&nbsp;&nbsp; PAR PHARM &nbsp;&nbsp;&nbsp; TWI PHARM Key Questions Addressed in this Report What is the 10-year outlook for the global Dexlansoprazole Sustained Release Capsule market? What factors are driving Dexlansoprazole Sustained Release Capsule market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Dexlansoprazole Sustained Release Capsule market opportunities vary by end market size? How does Dexlansoprazole Sustained Release Capsule break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Dexlansoprazole Sustained Release Capsule Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Dexlansoprazole Sustained Release Capsule by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Dexlansoprazole Sustained Release Capsule by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Dexlansoprazole Sustained Release Capsule Segment by Type &nbsp;2.2.1 30MG &nbsp;2.2.2 60MG &nbsp;2.3 Dexlansoprazole Sustained Release Capsule Sales by Type &nbsp;2.3.1 Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Dexlansoprazole Sustained Release Capsule Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Dexlansoprazole Sustained Release Capsule Sale Price by Type (2020-2025) &nbsp;2.4 Dexlansoprazole Sustained Release Capsule Segment by Application &nbsp;2.4.1 Hospital &nbsp;2.4.2 Clinic &nbsp;2.5 Dexlansoprazole Sustained Release Capsule Sales by Application &nbsp;2.5.1 Global Dexlansoprazole Sustained Release Capsule Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Dexlansoprazole Sustained Release Capsule Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Dexlansoprazole Sustained Release Capsule Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Dexlansoprazole Sustained Release Capsule Breakdown Data by Company &nbsp;3.1.1 Global Dexlansoprazole Sustained Release Capsule Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Dexlansoprazole Sustained Release Capsule Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Dexlansoprazole Sustained Release Capsule Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Dexlansoprazole Sustained Release Capsule Revenue by Company (2020-2025) &nbsp;3.2.2 Global Dexlansoprazole Sustained Release Capsule Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Dexlansoprazole Sustained Release Capsule Sale Price by Company &nbsp;3.4 Key Manufacturers Dexlansoprazole Sustained Release Capsule Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Dexlansoprazole Sustained Release Capsule Product Location Distribution &nbsp;3.4.2 Players Dexlansoprazole Sustained Release Capsule Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Dexlansoprazole Sustained Release Capsule by Geographic Region &nbsp;4.1 World Historic Dexlansoprazole Sustained Release Capsule Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Dexlansoprazole Sustained Release Capsule Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Dexlansoprazole Sustained Release Capsule Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Dexlansoprazole Sustained Release Capsule Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Dexlansoprazole Sustained Release Capsule Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Dexlansoprazole Sustained Release Capsule Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Dexlansoprazole Sustained Release Capsule Sales Growth &nbsp;4.4 APAC Dexlansoprazole Sustained Release Capsule Sales Growth &nbsp;4.5 Europe Dexlansoprazole Sustained Release Capsule Sales Growth &nbsp;4.6 Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales Growth 5 Americas &nbsp;5.1 Americas Dexlansoprazole Sustained Release Capsule Sales by Country &nbsp;5.1.1 Americas Dexlansoprazole Sustained Release Capsule Sales by Country (2020-2025) &nbsp;5.1.2 Americas Dexlansoprazole Sustained Release Capsule Revenue by Country (2020-2025) &nbsp;5.2 Americas Dexlansoprazole Sustained Release Capsule Sales by Type (2020-2025) &nbsp;5.3 Americas Dexlansoprazole Sustained Release Capsule Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Dexlansoprazole Sustained Release Capsule Sales by Region &nbsp;6.1.1 APAC Dexlansoprazole Sustained Release Capsule Sales by Region (2020-2025) &nbsp;6.1.2 APAC Dexlansoprazole Sustained Release Capsule Revenue by Region (2020-2025) &nbsp;6.2 APAC Dexlansoprazole Sustained Release Capsule Sales by Type (2020-2025) &nbsp;6.3 APAC Dexlansoprazole Sustained Release Capsule Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Dexlansoprazole Sustained Release Capsule by Country &nbsp;7.1.1 Europe Dexlansoprazole Sustained Release Capsule Sales by Country (2020-2025) &nbsp;7.1.2 Europe Dexlansoprazole Sustained Release Capsule Revenue by Country (2020-2025) &nbsp;7.2 Europe Dexlansoprazole Sustained Release Capsule Sales by Type (2020-2025) &nbsp;7.3 Europe Dexlansoprazole Sustained Release Capsule Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Dexlansoprazole Sustained Release Capsule by Country &nbsp;8.1.1 Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Dexlansoprazole Sustained Release Capsule Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Dexlansoprazole Sustained Release Capsule Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Dexlansoprazole Sustained Release Capsule &nbsp;10.3 Manufacturing Process Analysis of Dexlansoprazole Sustained Release Capsule &nbsp;10.4 Industry Chain Structure of Dexlansoprazole Sustained Release Capsule 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Dexlansoprazole Sustained Release Capsule Distributors &nbsp;11.3 Dexlansoprazole Sustained Release Capsule Customer 12 World Forecast Review for Dexlansoprazole Sustained Release Capsule by Geographic Region &nbsp;12.1 Global Dexlansoprazole Sustained Release Capsule Market Size Forecast by Region &nbsp;12.1.1 Global Dexlansoprazole Sustained Release Capsule Forecast by Region (2026-2031) &nbsp;12.1.2 Global Dexlansoprazole Sustained Release Capsule Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Dexlansoprazole Sustained Release Capsule Forecast by Type (2026-2031) &nbsp;12.7 Global Dexlansoprazole Sustained Release Capsule Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 TAKEDA PHARM &nbsp;13.1.1 TAKEDA PHARM Company Information &nbsp;13.1.2 TAKEDA PHARM Dexlansoprazole Sustained Release Capsule Product Portfolios and Specifications &nbsp;13.1.3 TAKEDA PHARM Dexlansoprazole Sustained Release Capsule Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 TAKEDA PHARM Main Business Overview &nbsp;13.1.5 TAKEDA PHARM Latest Developments &nbsp;13.2 PAR PHARM &nbsp;13.2.1 PAR PHARM Company Information &nbsp;13.2.2 PAR PHARM Dexlansoprazole Sustained Release Capsule Product Portfolios and Specifications &nbsp;13.2.3 PAR PHARM Dexlansoprazole Sustained Release Capsule Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 PAR PHARM Main Business Overview &nbsp;13.2.5 PAR PHARM Latest Developments &nbsp;13.3 TWI PHARM &nbsp;13.3.1 TWI PHARM Company Information &nbsp;13.3.2 TWI PHARM Dexlansoprazole Sustained Release Capsule Product Portfolios and Specifications &nbsp;13.3.3 TWI PHARM Dexlansoprazole Sustained Release Capsule Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 TWI PHARM Main Business Overview &nbsp;13.3.5 TWI PHARM Latest Developments 14 Research Findings and Conclusion

Report	Global Dexlansoprazole Sustained Release Capsule Market Growth, Trends and Opportunities 2025-31
Selected License	Multi ID: LPI49763

Buyer Information

Order Summary